columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiske midler - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
britaject 10 mg/ ml
stada arzneimittel ag - apomorfinhydrokloridhemihydrat - injeksjonsvæske, oppløsning i ferdigfylt penn - 10 mg/ ml
mirtazapin bluefish 45 mg
bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 45 mg
mirtazapin bluefish 15 mg
bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 15 mg
mirtazapin bluefish 30 mg
bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 30 mg
lifmior
pfizer europe ma eeig - etanercept - arthritis, psoriatic; spondylitis, ankylosing; psoriasis - immunsuppressive - revmatoid artritt;juvenil idiopatisk arthritispsoriatic leddgikt;aksial spondyloarthritis;plaque psoriasis;paediatric plakkpsoriasis.
naloxon b. braun 0.4 mg/ ml
b. braun melsungen ag - naloksonhydrokloriddihydrat - injeksjons-/infusjonsvæske, oppløsning - 0.4 mg/ ml
naloxon hameln 0.4 mg/ ml
hameln pharma gmbh - naloksonhydrokloriddihydrat - injeksjons-/infusjonsvæske, oppløsning - 0.4 mg/ ml
amikacin macure 250 mg/ ml
macure pharma aps - amikacinsulfat - injeksjonsvæske, oppløsning - 250 mg/ ml